550 related articles for article (PubMed ID: 31001900)
21. Secreted Frizzled-Related Protein 5 Attenuates High Phosphate-Induced Calcification in Vascular Smooth Muscle Cells by Inhibiting the Wnt/ß-Catenin Pathway.
Deng D; Diao Z; Han X; Liu W
Calcif Tissue Int; 2016 Jul; 99(1):66-75. PubMed ID: 26895007
[TBL] [Abstract][Full Text] [Related]
22. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
[TBL] [Abstract][Full Text] [Related]
23. Effect of pioglitazone on the calcification of rat vascular smooth muscle cells through the downregulation of the Wnt/β‑catenin signaling pathway.
Gao M; Chen T; Wu L; Zhao X; Mao H; Xing C
Mol Med Rep; 2017 Nov; 16(5):6208-6213. PubMed ID: 28849074
[TBL] [Abstract][Full Text] [Related]
24. κ-opioid receptor stimulation alleviates rat vascular smooth muscle cell calcification via PFKFB3-lactate signaling.
Niu J; Wu C; Zhang M; Yang Z; Liu Z; Fu F; Li J; Feng N; Gu X; Zhang S; Liu Y; Fan R; Li J; Pei J
Aging (Albany NY); 2021 May; 13(10):14355-14371. PubMed ID: 34016793
[TBL] [Abstract][Full Text] [Related]
25. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.
Nie B; Zhang SY; Guan SM; Zhou SQ; Fang X
Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488
[TBL] [Abstract][Full Text] [Related]
26. Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt/β-catenin pathway.
Rong S; Zhao X; Jin X; Zhang Z; Chen L; Zhu Y; Yuan W
Cell Physiol Biochem; 2014; 34(6):2049-60. PubMed ID: 25562153
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
28. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of HOTAIR attenuates Pi-induced vascular calcification by inhibiting Wnt/β-catenin through regulating miR-126/Klotho/SIRT1 axis.
Chen Y; Huang C; Zhu SY; Zou HC; Xu CY; Chen YX
Mol Cell Biochem; 2021 Oct; 476(10):3551-3561. PubMed ID: 34014438
[TBL] [Abstract][Full Text] [Related]
30. Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling.
Ning FL; Tao J; Li DD; Tian LL; Wang ML; Reilly S; Liu C; Cai H; Xin H; Zhang XM
Acta Pharmacol Sin; 2022 Mar; 43(3):624-633. PubMed ID: 34163023
[TBL] [Abstract][Full Text] [Related]
31. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
Yao L; Sun YT; Sun W; Xu TH; Ren C; Fan X; Sun L; Liu LL; Feng JM; Ma JF; Wang LN
Am J Nephrol; 2015; 41(1):28-36. PubMed ID: 25634106
[TBL] [Abstract][Full Text] [Related]
32. HIF-1α/PDK4/autophagy pathway protects against advanced glycation end-products induced vascular smooth muscle cell calcification.
Yang R; Zhu Y; Wang Y; Ma W; Han X; Wang X; Liu N
Biochem Biophys Res Commun; 2019 Sep; 517(3):470-476. PubMed ID: 31376939
[TBL] [Abstract][Full Text] [Related]
33. Wnt5a is associated with the differentiation of bone marrow mesenchymal stem cells in vascular calcification by connecting with different receptors.
Guan S; Wang Z; Xin F; Xin H
Mol Med Rep; 2014 Oct; 10(4):1985-91. PubMed ID: 25109262
[TBL] [Abstract][Full Text] [Related]
34. The suppressive effect of soluble Klotho on fibroblastic growth factor 23 synthesis in UMR-106 osteoblast-like cells.
Ma L; Gao M; Wu L; Zhao X; Mao H; Xing C
Cell Biol Int; 2018 Sep; 42(9):1270-1274. PubMed ID: 29851201
[TBL] [Abstract][Full Text] [Related]
35. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation.
Martínez-Moreno JM; Muñoz-Castañeda JR; Herencia C; Oca AM; Estepa JC; Canalejo R; Rodríguez-Ortiz ME; Perez-Martinez P; Aguilera-Tejero E; Canalejo A; Rodríguez M; Almadén Y
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1136-44. PubMed ID: 22874762
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.
Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M
FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells.
Nakahara T; Kawai-Kowase K; Matsui H; Sunaga H; Utsugi T; Iso T; Arai M; Tomono S; Kurabayashi M
Atherosclerosis; 2016 Oct; 253():102-110. PubMed ID: 27599364
[TBL] [Abstract][Full Text] [Related]
38. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin protects vascular smooth muscle cells from TGF-β1-stimulated calcification by inducing autophagy via suppression of the β-catenin pathway.
Liu D; Cui W; Liu B; Hu H; Liu J; Xie R; Yang X; Gu G; Zhang J; Zheng H
Cell Physiol Biochem; 2014; 33(1):129-41. PubMed ID: 24481040
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of the Fibroblast Growth Factor 23/α-Klotho Axis in Peripheral Blood Mononuclear Cell Inflammation in Alzheimer's Disease.
Li B; Zhou M; Peng J; Yang Q; Chu J; Li R; Jiang Y
Immunol Invest; 2022 Jul; 51(5):1471-1484. PubMed ID: 34503373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
